Hello all–
This is my first time joining a forum! I’m working with both Truven and Optum data that have been converted to OMOP v5, and I have found that the neither the NDC code nor the HCPCS code for daratumumab (Darzalex) have been mapped into the medication_exposure table (or the procedure table, in the case of HCPCS). The drug was first approved in 2015. Is there an expected time frame for inclusion into the OMOP vocabulary? Tagging @krfeeney and @seslava in case I missed any important details.
Many thanks,
Julianna